The trial, part of the federal government’s Operation Warp Speed, involves 30,000 patients.
Moderna said it is making changes to the trial’s protocol, which has pushed back the expected start date. CEO Stéphane Bancel told CNBC the drugmaker still intends to start the trial in July but did not give a definitive date.
Researchers told STAT that protocol changes are common in clinical trials.
Moderna said July 2 on Twitter that it has worked closely with the National Institutes of Health to “align on the final protocol.”
Read the full article here.
More articles on pharmacy:
Novartis to pay $678M to settle kickback lawsuit
Drug lobby sues Minnesota over insulin-pricing law
Independent Idaho pharmacy joins Kootenai Health
